Hydrocarbon waxes
CAS 8002-74-2
Hydrocarbon waxes (CAS 8002-74-2) is a pharmaceutical compound with 0 bioactivity targets and 192 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Hydrocarbon waxes is linked to DTXSID7027673 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hydrocarbon waxes used for in pharmaceutical contexts?
Hydrocarbon waxes (CAS 8002-74-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hydrocarbon waxes?
Hydrocarbon waxes has 192 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Accidental overdose, Acute myocardial infarction, Adverse drug reaction, Alcohol poisoning. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hydrocarbon waxes also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Candelilla Wax with EU status "permitted".
What clinical phase is Hydrocarbon waxes in?
No phase 1-4 clinical development badge is rendered for Hydrocarbon waxes because the matched compound identifier rows do not contain a max-phase value.